Pembrolizumab in advanced pretreated small cell lung cancer patients with PD-L1 expression: data from the KEYNOTE-028 trial: a reason for hope?
2017 ◽
Vol 6
(S1)
◽
pp. S78-S83
◽
Keyword(s):
Keyword(s):
Keyword(s):
2012 ◽
Vol 5
(1)
◽
pp. 38-42
Keyword(s):
Keyword(s):